Glycichek MP 1mg/500mg/15mg Tablet
Marketer
Astorion Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glycichek MP 1mg/500mg/15mg Tablet
Metformin/glimepiride/pioglitazone (1mg/500mg/15mg) tablets manage blood glucose in adults with type 2 diabetes. This triple-combination therapy complements dietary and exercise regimens to enhance glycemic control. It improves insulin effectiveness, reducing blood sugar. Dosage and duration should strictly follow your physician's instructions. Take with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose. Overdosing can cause hypoglycemia. Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to use, disclose kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation. Kidney function tests are usually performed before treatment initiation. Limit alcohol consumption as it may worsen side effects.
Uses of Glycichek MP 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glycichek MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glycichek MP 1mg/500mg/15mg Tablets should be administered with a meal.
Common Side effects of Glycichek MP 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glycichek MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glycichek MP 1mg/500mg/15mg Tablets should be administered with food.
How Glycichek MP 1mg/500mg/15mg Tablet works:
Glycichek MP 1mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts triply by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glycichek MP 1mg/500mg/15mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glycichek MP 1mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks before prescribing this medication. Seek medical advice before taking this medication if you are pregnant.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Glycichek MP 1mg/500mg/15mg Tablet use are likely incompatible. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired if your blood glucose level is abnormally low or elevated. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Glycichek MP 1mg/500mg/15mg tablets, potentially requiring dosage modification under medical supervision. The medication is contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glycichek MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Glycichek MP 1mg/500mg/15mg tablets are contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glycichek MP 1mg/500mg/15mg Tablet :
Should you forget a Glycichek MP 1mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glycichek MP 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Medication for diabetes |
3,018 People bought this recently